ATTD: Advanced Technologies and Treatments for Diabetes

In this episode of ATTD 2026 Conference Catch-Up, we dive into Advancements in Type 1 Diabetes: From Pathogenesis to Therapy, featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies. 
Join us as we summarize key takeaways from these thought-provoking presentations: 
Role of Viruses in Pathogenesis of Type 1 Diabetes – Dr. Teresa Rodriguez-Calvo 

Dendritic Cells for Treatment of Type 1 Diabetes – Dr. Jason Gaglia 

C-Peptide: A Marker for Functional Beta Cell Mass? – Prof. Chantal Mathieu 

This episode is an essential listen for endocrinologists, researchers, and healthcare professionals specializing in diabetes care, providing insights into the evolving landscape of Type 1 diabetes pathogenesis and the potential of dendritic cell therapies. 
Enjoy the listen! 
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 
ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

In this episode of ATTD 2026 Conference Catch-Up, we dive into ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care, where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use. 
Join us as we summarize key takeaways from these thought-provoking presentations: 
Welcome & Framing – Dr. Amit Dey & Prof. Peter Schwarz 

Foundations of AI & Gen-AI for Clinicians – Dr. Amit Dey 

Agentic AI & CDSS Workflows in Diabetes Care – Dr. Revital Nimri 

Ethics, EU AI Act & GDPR Essentials for Clinicians – Lucía Feito Allonca 

This episode is an essential listen for clinicians, diabetes specialists, and healthcare professionals seeking to understand the practical, safe, and ethical integration of GenAI and AI-driven clinical decision support systems (CDSS) in diabetes care. 
Enjoy the listen! 
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 
ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

In this episode of ATTD 2026 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) Outside the Traditional Areas, exploring innovative applications of CGM beyond its conventional use in diabetes management. 
Join us as we summarize key takeaways from these thought-provoking presentations: 
CGM As a Guide to Lifestyle and Weight Management – Dr. Nicola Guess 

CGM in Non-diabetic Hypoglycaemia (Insulinoma, Post-bariatric / Reactive) – Dr. Robert Andrews 

Non-invasive Glucose Monitoring – Dr. Lutz Heinemann 

CGM Use in Clinical Trials – Prof. Pratik Choudhary 

This episode is an essential listen for endocrinologists, clinical researchers, and healthcare professionals looking to explore the expanding role of CGM in lifestyle management, non-diabetic hypoglycaemia, and innovative clinical applications. 
Enjoy the listen! 
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 
ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

In this episode of ATTD 2026 Conference Catch-Up, we dive into Cardiovascular Disease in Type 1 Diabetes, featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes. 
While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular burden in individuals with Type 1 diabetes. This session explores the mechanisms, clinical risk factors, and multidisciplinary interventions that can help reduce long-term cardiovascular complications in this population. 
Join us as we summarize key takeaways from these thought-provoking presentations: 
• Coronary Heart Disease in T1D, Is It Different Than in T2D? – Dr. Robert H. Eckel 
• Targets and Best Therapies for Blood Pressure and Cholesterol – Oliver Schnell 
• Physical Activity for Cardiometabolic Risk Reduction in Type 1 Diabetes – Prof. Kirsten Nørgaard 
• Understanding the Etiology and Best Treatment Strategies for Obesity in Type 1 Diabetes – Dr. Irl B. Hirsch 
This episode is an essential listen for endocrinologists, diabetologists, cardiometabolic specialists, and healthcare professionals involved in diabetes care looking to better understand cardiovascular risk management and prevention strategies in people with Type 1 diabetes. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. 

https://attd.kenes.com

In this episode of ATTD 2026 Conference Catch-Up, we dive into Refining Care of Type 1 Diabetes, featuring the latest advancements and strategies aimed at improving the care and outcomes for individuals living with Type 1 diabetes. 
Join us as we summarize key takeaways from these thought-provoking presentations: 
Refining Care of Type 1 Diabetes – Dr. Lori Laffel 

Improving Glycemic Control and Reducing Diabetes Distress: A 2-way Street – Prof. Katharine Barnard-Kelly 

Targeting Lower Glucose Levels in Children with Type 1 Diabetes – Dr. David M. Maahs 

Inhaled Insulin Use in Pediatrics – Inhale 1 Study – Dr. Roy W. Beck 

This episode is an essential listen for endocrinologists, pediatric specialists, and healthcare professionals involved in diabetes care, looking to refine their approach to treating Type 1 diabetes with the latest research findings and practical strategies. 
Enjoy the listen! 
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 
ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com